U.S. Court of Appeals for the Federal Circuit, 2023

Astrazeneca Ab v. Mylan Pharmaceuticals Inc.

Astrazeneca Ab v. Mylan Pharmaceuticals Inc.
U.S. Court of Appeals for the Federal Circuit · Decided March 7, 2023
Astrazeneca Ab v. Mylan Pharmaceuticals Inc.

Opinion

Case: 23-1164 Document: 65 Page: 1 Filed: 03/07/2023

NOTE: This order is nonprecedential.

United States Court of Appeals for the Federal Circuit ______________________

ASTRAZENECA AB, ASTRAZENECA

PHARMACEUTICALS LP,

Plaintiffs-Appellants v.

MYLAN PHARMACEUTICALS INC., KINDEVA

DRUG DELIVERY L.P.,

Defendants-Appellees ______________________

2023-1164 ______________________

Appeal from the United States District Court for the Northern District of West Virginia in Nos. 1:18-cv-00193- IMK-RWT, 1:19-cv-203-IMK-RWT, Judge Irene M. Keeley. ______________________

ON MOTION ______________________

PER CURIAM.

ORDER

The parties jointly move to remand the above-cap- tioned appeal with each side to bear its own costs and fees. Upon consideration thereof,

IT IS ORDERED THAT: Case: 23-1164 Document: 65 Page: 2 Filed: 03/07/2023

2 ASTRAZENECA AB v. MYLAN PHARMACEUTICALS INC.

The motion is granted.

FOR THE COURT March 7, 2023 /s/ Peter R. Marksteiner Date Peter R. Marksteiner Clerk of Court

ISSUED AS A MANDATE: March 7, 2023

Case-law data current through September 30, 2026. Source: CourtListener bulk data.